Phase II clinical trial to validate usefulness of pioglitazone to differentiate cancerous from inflammatory lesions in patients undergoing FDG PET/CT
Yeon‐Hee Han(Jeonbuk National University), Hwan‐Jeong Jeong(Chonnam National University), Chang Ju Na(Jeonbuk National University), Eun‐Mi Kim(Dong-A University), Seok Tae Lim(Columbia University Irving Medical Center), Myung‐Hee Sohn(University of Rochester), Sehun Choi(Jeonbuk National University), Jeong Hun Kim(Seoul National University Hospital)
Journal of Nuclear Medicine
May 1, 2014
Cited by 0
Related Papers
Facile Nucleophilic Fluorination Reactions Using <i>tert</i>-Alcohols as a Reaction Medium: Significantly Enhanced Reactivity of Alkali Metal Fluorides and Improved Selectivity
|The Journal of Organic Chemistry|2008|175
Mesoporous Silica Nanoparticle Pretargeting for PET Imaging Based on a Rapid Bioorthogonal Reaction in a Living Body
|Angewandte Chemie International Edition|2013|170
Tetrabutylammonium Tetra(<i>tert</i>‐Butyl Alcohol)‐Coordinated Fluoride as a Facile Fluoride Source
|Angewandte Chemie International Edition|2008|156
Tetrabutylammonium Tetra(<i>tert</i>‐Butyl Alcohol)‐Coordinated Fluoride as a Facile Fluoride Source
|Angewandte Chemie|2008|132
Hypoxia-inducible Factor-1α Inhibits Self-renewal of Mouse Embryonic Stem Cells in Vitro via Negative Regulation of the Leukemia Inhibitory Factor-STAT3 Pathway
|Journal of Biological Chemistry|2007|115